Threat of Avian Flu Pandemic Escalates Need for Biological Countermeasures
November 4, 2005 (Press Release) --
BiodefenseStocks.com Reports on Project BioShield; Working to Defend Against Bioterrorism through a Stronger Biodefense Arena
Threat of Avian Flu Pandemic Escalates Need for Biological Countermeasures
www.BiodefenseStocks.com (BDS), and www.HomelandDefenseStocks.com (HDS), investor news portals for the Biodefense and Homeland Security sectors, report on the growth of the biodefense arena in light of the challenges and opportunities realized through Project BioShield. Punk, Ziegel & Company’s Senior Biotechnology Analyst, Sharon Seiler provides perspective on the current environment under BioShield, while Hollis-Eden Pharmaceuticals, Inc. (NASDQ: HEPH), VaxGen Inc. (OTC.PK: VXGN), Aethlon Medical, Inc. (OTCBB: AEMD) and Acambis plc (LSE: ACM) reveal industry insights.
Full Article: http://www.biodefensestocks.com/BDS/News/Project_BioShield.asp
Full News: http://www.investorideas.com/Companies/ViewDocument.asp?ID=3624
Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Threat of Avian Flu Pandemic Escalates Need for Biological Countermeasures
www.BiodefenseStocks.com (BDS), and www.HomelandDefenseStocks.com (HDS), investor news portals for the Biodefense and Homeland Security sectors, report on the growth of the biodefense arena in light of the challenges and opportunities realized through Project BioShield. Punk, Ziegel & Company’s Senior Biotechnology Analyst, Sharon Seiler provides perspective on the current environment under BioShield, while Hollis-Eden Pharmaceuticals, Inc. (NASDQ: HEPH), VaxGen Inc. (OTC.PK: VXGN), Aethlon Medical, Inc. (OTCBB: AEMD) and Acambis plc (LSE: ACM) reveal industry insights.
Full Article: http://www.biodefensestocks.com/BDS/News/Project_BioShield.asp
Full News: http://www.investorideas.com/Companies/ViewDocument.asp?ID=3624
Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Email
Print
SPAM
LEAVE A COMMENT
